Cite

    Galsky, M., Noah, H., Starodub, A., Hauke, R., Twardowski, P., Fleming, M., Qi, J., Sonpavde, G., Patel, M., Zhu, J., Chippada-Venkata, U., Albany, C., Wang, L., Merad, M., Oh, W., Bhardwaj, N., Gnjatic, S., & Kim-Schulze, S. (2015). impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer. Journal for immunotherapy of cancer, 3(2), 1–2. http://access.bl.uk/ark:/81055/vdc_100080441580.0x00055e